---
title: "Functional Tertiary Lymphoid Structures in Human Gliomas"
author: "Group 21"
format:
  revealjs:
    incremental: true  
    theme: serif
    slide-number: true
    css: styles.css
    margin: 0.04
    embed-resources: true
    footer: ""
---

## Introduction

![](images/Title_article.png){width="28cm" height="4cm"}

![](images/Graphical_summary_article.png){width="12cm" height="10cm"}

------------------------------------------------------------------------

## Materials and Methods

#### Materials:

-   Metadata: \[GEO (NCBI) - GSE271059\]

    -   IDH_status

    -   TLS_status

    -   Localisation

    -   Primary_or_Recurrent

    -   Age

    -   Gender

-   Raw data: gene expression count matrix (genes × samples)

::: footer
<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271059>
:::

------------------------------------------------------------------------

#### Methods:

::: panel-tabset
## Data Loading and Cleaning

-   **Loading data**

    -   read_csv()

-   **Cleaning data**

    -   Replacing "Not_Available" with NA

    -   Removing duplicates: distinct()

    -   Standardizing names

## Data Augmentation

-   **Creating new metadata columns**

    -   Age_groups

    -   TLS_status_bin

-   **Normalizing gene expression**

    -   cpm_normalization

    -   quantile_normalization

-   **Computing GEP scores**

-   **Combining normalized counts with metadata**

-   **Preparing data for PCA/downstream analysis**
:::

------------------------------------------------------------------------

#### Methods:

::: panel-tabset
## Descriptive Statistics

-   **Baseline tables**

    -   TLS_status: IDH_status, Gender, Age, Localisation
    -   IDH_status: TLS_status, Gender, Age, Localisation

-   **PCA on gene expression**

    -   PC1–PC2 coloured by TLS_status
    -   PC1–PC2 coloured by IDH_status
    -   Variance explained by PCs

## Statistical Models

-   **Model 1 – TLS effect on gene expression**
    -   CPM_log2 \~ TLS_status_bin
    -   Output: volcano plot (TLS+ vs TLS−)
-   **Model 2 – GEP scoreby TLS status**
    -   GEP_score \~ TLS_status_bin
-   **Model 3 – TLS and clinical features (Fisher tests)**
    -   TLS_status_bin vs IDH_status
    -   TLS_status_bin vs Primary/Recurrent
    -   TLS_status_bin vs Gender
:::

------------------------------------------------------------------------

##### Results

#### Impact of TLS status on transcriptional signatures

::::: columns
::: {.column width="50%"}
![](images/TLS_status_PCA-03.png)
:::

::: {.column width="50%"}
-   TLS status does not strongly separate the samples

-   TLS group contains highly distinct outliers
:::
:::::

------------------------------------------------------------------------

##### Results

#### Impact of IDH status on transcriptional signatures

::::: columns
::: {.column width="70%"}
![](images/IDH_status_PCA-01.png)
:::

::: {.column width="30%"}
-   Clear and distinct separation of samples by IDH status

-   Outlier subsets exist
:::
:::::

------------------------------------------------------------------------

##### Results

#### TLS effect on gene expression

::::: columns
::: {.column width="70%"}
![](images/volcano_plot.png)
:::

::: {.column width="30%"}
-   Each point = one gene (TLS+ vs TLS−)
-   Several genes are significantly associated with TLS status (q \< 0.01)
-   Some genes higher in TLS+, others in controls\
    → TLS status is linked to differences in gene expression
:::
:::::

------------------------------------------------------------------------

##### Results

#### GEP score by TLS status

::::: columns
::: {.column width="70%"}
![](images/GEP_score_vs_TLS_status.png)
:::

::: {.column width="30%"}
-   Each point = one tumor sample
-   GEP score (18-gene immune signature)
-   Median GEP score is higher in TLS+ tumors than in controls
:::
:::::

------------------------------------------------------------------------

##### Results

::::: columns
::: {.column width="70%"}
![](images/significant_genes_overlap.png)
:::

::: {.column width="30%"}
:::
:::::

------------------------------------------------------------------------

##### Results

#### TLS and clinical features (Fisher's tests)

:::::: columns
::: {.column width="33%"}
![](images/TLS_vs_IDH_heatmap-03.png)
:::

::: {.column width="33%"}
![](images/TLS_vs_tumor_status-03.png)
:::

::: {.column width="33%"}
![](images/TLS_vs_gender-03.png)
:::
::::::

------------------------------------------------------------------------

## Discussion
